Cochlear | COH - Net Income

Stock Price
250.17
Daily Change
-8.57 -3.31%
Monthly
-4.74%
Yearly
-19.25%
Q1 Forecast
263.64

Cochlear reported AUD91.9M in Net Income for its fiscal semester ending in June of 2025.





Net Income Change Date
Ansell USD 23.3M 33.8M Jun/2025
Avita Medical AUD -9.92M 1.67M Jun/2025
Cochlear AUD 91.9M 113.2M Jun/2025
CSL USD 497.5M 1.51B Jun/2025
Fisher Paykel Healthcare NZD 213M 11M Dec/2025
Healius AUD -12.8M 7.8M Dec/2024
Integral Diagnostics AUD 6.06M 72.81M Jun/2024
Mayne Pharma AUD -103.68M 68.4M Jun/2024
Mesoblast USD -54.21M 6.27M Jun/2025
Monash IVF AUD 4M 13.01M Jun/2025
Nanosonics AUD 5.46M 4.3M Jun/2025
Polynovo AUD 1.28M 1.41M Jun/2024
Ramsay Health Care AUD 120.3M 225.2M Jun/2025
Regis Healthcare AUD 12.3M 12.06M Jun/2025
ResMed USD 392.59M 44.05M Dec/2025
Sigma Healthcare AUD -6.72M 10.02M Dec/2024
Sonic Healthcare AUD 236.68M 82.29M Dec/2024
Telix Pharmaceuticals AUD 10.13M 19.52M Dec/2024